25-02-2025 | Artificial Intelligence | REVIEW
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges
Published in: Current Oncology Reports
Login to get accessPlease log in to get access to this content
Appendix
Available only for authorised users
Literature
1.
go back to reference Kurian N, Cherian JM, Sudharson NA, Varghese KG, Wadhwa S. AI is now everywhere. Br Dent J. 2023;234:72–72.CrossRefPubMed
Kurian N, Cherian JM, Sudharson NA, Varghese KG, Wadhwa S. AI is now everywhere. Br Dent J. 2023;234:72–72.CrossRefPubMed
2.
go back to reference U D, Z D, W HJ. ChatGPT-A promising generative AI tool and its implications for cancer care. Cancer [Internet]. 2023;129. Available from: http://pubmed.ncbi.nlm.nih.gov/37183438/. Accessed 25 Feb 2024.
U D, Z D, W HJ. ChatGPT-A promising generative AI tool and its implications for cancer care. Cancer [Internet]. 2023;129. Available from: http://pubmed.ncbi.nlm.nih.gov/37183438/. Accessed 25 Feb 2024.
3.
go back to reference Johnson SB, King AJ, Warner EL, Aneja S, Kann BH, Bylund CL. Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information. JNCI Cancer Spectr [Internet]. 2023;7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020140/. Accessed 26 Sept 2023.
Johnson SB, King AJ, Warner EL, Aneja S, Kann BH, Bylund CL. Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information. JNCI Cancer Spectr [Internet]. 2023;7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020140/. Accessed 26 Sept 2023.
4.
go back to reference Zhu L, Mou W, Chen R. Can the ChatGPT and other large language models with internet-connected database solve the questions and concerns of patient with prostate cancer and help democratize medical knowledge? J Transl Med. 2023;21:1–4.CrossRef
Zhu L, Mou W, Chen R. Can the ChatGPT and other large language models with internet-connected database solve the questions and concerns of patient with prostate cancer and help democratize medical knowledge? J Transl Med. 2023;21:1–4.CrossRef
5.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.CrossRefPubMed
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.CrossRefPubMed
6.
go back to reference Siri, Siri, in my hand: Who’s the fairest in the land? On the interpretations, illustrations, and implications of artificial intelligence - ScienceDirect [Internet]. 2018. Available from: https://web.archive.org/web/20181121191205/https://www.sciencedirect.com/science/article/pii/S0007681318301393. Accessed 24 Sept 2023.
Siri, Siri, in my hand: Who’s the fairest in the land? On the interpretations, illustrations, and implications of artificial intelligence - ScienceDirect [Internet]. 2018. Available from: https://web.archive.org/web/20181121191205/https://www.sciencedirect.com/science/article/pii/S0007681318301393. Accessed 24 Sept 2023.
7.
go back to reference Ramesh AN, Kambhampati C, Monson JRT, Drew PJ. Artificial intelligence in medicine. Ann R Coll Surg Engl. 2004;86:334–8.CrossRefPubMedPubMedCentral
Ramesh AN, Kambhampati C, Monson JRT, Drew PJ. Artificial intelligence in medicine. Ann R Coll Surg Engl. 2004;86:334–8.CrossRefPubMedPubMedCentral
8.
go back to reference What is artificial intelligence? [Internet]. 2015. Available from: https://web.archive.org/web/20151118212402/http://www-formal.stanford.edu/jmc/whatisai/whatisai.html. Accessed 24 Sept 2023.
What is artificial intelligence? [Internet]. 2015. Available from: https://web.archive.org/web/20151118212402/http://www-formal.stanford.edu/jmc/whatisai/whatisai.html. Accessed 24 Sept 2023.
9.
go back to reference Zhang C, Lu Y. Study on artificial intelligence: The state of the art and future prospects. J Ind Inf Integr. 2021;23:100224.
Zhang C, Lu Y. Study on artificial intelligence: The state of the art and future prospects. J Ind Inf Integr. 2021;23:100224.
10.
go back to reference Shortliffe EH, Davis R, Axline SG, Buchanan BG, Green CC, Cohen SN. Computer-based consultations in clinical therapeutics: Explanation and rule acquisition capabilities of the MYCIN system. Comput Biomed Res. 1975;8:303–20.CrossRefPubMed
Shortliffe EH, Davis R, Axline SG, Buchanan BG, Green CC, Cohen SN. Computer-based consultations in clinical therapeutics: Explanation and rule acquisition capabilities of the MYCIN system. Comput Biomed Res. 1975;8:303–20.CrossRefPubMed
11.
go back to reference Buchanan B, Shortliffe E. Rule-based Expert System – The MYCIN Experiments of the Stanford Heuristic Programming Project. SERBIULA Sist. Libr. 20. 1984. https://doi.org/10.1016/0004-3702(85)90067-0.
Buchanan B, Shortliffe E. Rule-based Expert System – The MYCIN Experiments of the Stanford Heuristic Programming Project. SERBIULA Sist. Libr. 20. 1984. https://doi.org/10.1016/0004-3702(85)90067-0.
12.
go back to reference Rayhan S, Gross D. Revolutionizing intelligence: Unraveling the frontiers of advanced artificial intelligence and its impact on society. 2023. https://doi.org/10.13140/RG.2.2.18500.60808.
Rayhan S, Gross D. Revolutionizing intelligence: Unraveling the frontiers of advanced artificial intelligence and its impact on society. 2023. https://doi.org/10.13140/RG.2.2.18500.60808.
13.
go back to reference Averkin AN, Yarushev SA. Evolution of artificial neural networks. 2018. Available from: https://libeldoc.bsuir.by/handle/123456789/30338. Accessed 26 Mar 2024.
Averkin AN, Yarushev SA. Evolution of artificial neural networks. 2018. Available from: https://libeldoc.bsuir.by/handle/123456789/30338. Accessed 26 Mar 2024.
14.
go back to reference Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak. 2019;19:281.CrossRefPubMedPubMedCentral
Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak. 2019;19:281.CrossRefPubMedPubMedCentral
15.
go back to reference Kavakiotis I, Tsave O, Salifoglou A, Maglaveras N, Vlahavas I, Chouvarda I. Machine learning and data mining methods in diabetes research. Comput Struct Biotechnol J. 2017;15:104–16.CrossRefPubMedPubMedCentral
Kavakiotis I, Tsave O, Salifoglou A, Maglaveras N, Vlahavas I, Chouvarda I. Machine learning and data mining methods in diabetes research. Comput Struct Biotechnol J. 2017;15:104–16.CrossRefPubMedPubMedCentral
16.
go back to reference Sharma S, Aggarwal A, Choudhury T. Breast cancer detection using machine learning algorithms. 2018 Int Conf Comput Tech Electron Mech Syst CTEMS [Internet]. 2018 . pp. 114–8. Available from: https://ieeexplore.ieee.org/abstract/document/8769187. Accessed 26 Sept 2023.
Sharma S, Aggarwal A, Choudhury T. Breast cancer detection using machine learning algorithms. 2018 Int Conf Comput Tech Electron Mech Syst CTEMS [Internet]. 2018 . pp. 114–8. Available from: https://ieeexplore.ieee.org/abstract/document/8769187. Accessed 26 Sept 2023.
17.
go back to reference LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44.CrossRefPubMed
LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44.CrossRefPubMed
18.
go back to reference Nadkarni PM, Ohno-Machado L, Chapman WW. Natural language processing: an introduction. J Am Med Inform Assoc. 2011;18:544–51.CrossRefPubMedPubMedCentral
Nadkarni PM, Ohno-Machado L, Chapman WW. Natural language processing: an introduction. J Am Med Inform Assoc. 2011;18:544–51.CrossRefPubMedPubMedCentral
19.
go back to reference Kreimeyer K, Foster M, Pandey A, Arya N, Halford G, Jones SF, et al. Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review. J Biomed Inform. 2017;73:14–29.CrossRefPubMedPubMedCentral
Kreimeyer K, Foster M, Pandey A, Arya N, Halford G, Jones SF, et al. Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review. J Biomed Inform. 2017;73:14–29.CrossRefPubMedPubMedCentral
20.
go back to reference Sheikhalishahi S, Miotto R, Dudley JT, Lavelli A, Rinaldi F, Osmani V. Natural language processing of clinical notes on chronic diseases: systematic review. JMIR Med Inform. 2019;7:e12239.CrossRefPubMedPubMedCentral
Sheikhalishahi S, Miotto R, Dudley JT, Lavelli A, Rinaldi F, Osmani V. Natural language processing of clinical notes on chronic diseases: systematic review. JMIR Med Inform. 2019;7:e12239.CrossRefPubMedPubMedCentral
21.
go back to reference Yang X, Mu D, Peng H, Li H, Wang Y, Wang P, et al. Research and application of artificial intelligence based on electronic health records of patients with cancer: systematic review. JMIR Med Inform. 2022;10:e33799.CrossRefPubMedPubMedCentral
Yang X, Mu D, Peng H, Li H, Wang Y, Wang P, et al. Research and application of artificial intelligence based on electronic health records of patients with cancer: systematic review. JMIR Med Inform. 2022;10:e33799.CrossRefPubMedPubMedCentral
22.
go back to reference G E. The Role of ChatGPT, Generative language models, and artificial intelligence in medical education: A conversation with ChatGPT and a call for papers. JMIR Med Educ [Internet]. 2023;9. Available from: http://pubmed.ncbi.nlm.nih.gov/36863937/. Accessed 4 Oct 2023.
G E. The Role of ChatGPT, Generative language models, and artificial intelligence in medical education: A conversation with ChatGPT and a call for papers. JMIR Med Educ [Internet]. 2023;9. Available from: http://pubmed.ncbi.nlm.nih.gov/36863937/. Accessed 4 Oct 2023.
23.
go back to reference Lee P, Bubeck S, Petro J. Benefits, limits, and risks of GPT-4 as an AI chatbot for medicine. N Engl J Med. 2023;388:1233–9.CrossRefPubMed
Lee P, Bubeck S, Petro J. Benefits, limits, and risks of GPT-4 as an AI chatbot for medicine. N Engl J Med. 2023;388:1233–9.CrossRefPubMed
24.
go back to reference Keifenheim KE, Teufel M, Ip J, Speiser N, Leehr EJ, Zipfel S, et al. Teaching history taking to medical students: a systematic review. BMC Med Educ. 2015;15:1–12.CrossRef
Keifenheim KE, Teufel M, Ip J, Speiser N, Leehr EJ, Zipfel S, et al. Teaching history taking to medical students: a systematic review. BMC Med Educ. 2015;15:1–12.CrossRef
25.
go back to reference Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81–94.CrossRefPubMed
Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81–94.CrossRefPubMed
26.
go back to reference Blum J, et al. Pearls and pitfalls of ChatGPT in medical oncology. Trends Cancer. 2023;9:788–90.CrossRefPubMed
Blum J, et al. Pearls and pitfalls of ChatGPT in medical oncology. Trends Cancer. 2023;9:788–90.CrossRefPubMed
27.
go back to reference Campanella P, Lovato E, Marone C, Fallacara L, Mancuso A, Ricciardi W, et al. The impact of electronic health records on healthcare quality: a systematic review and meta-analysis. Eur J Public Health. 2016;26:60–4.CrossRefPubMed
Campanella P, Lovato E, Marone C, Fallacara L, Mancuso A, Ricciardi W, et al. The impact of electronic health records on healthcare quality: a systematic review and meta-analysis. Eur J Public Health. 2016;26:60–4.CrossRefPubMed
28.
go back to reference Huang H, Zheng O, Wang D, Yin J, Wang Z, Ding S, et al. ChatGPT for shaping the future of dentistry: the potential of multi-modal large language model. Int J Oral Sci. 2023;15:1–13.CrossRefPubMedPubMedCentral
Huang H, Zheng O, Wang D, Yin J, Wang Z, Ding S, et al. ChatGPT for shaping the future of dentistry: the potential of multi-modal large language model. Int J Oral Sci. 2023;15:1–13.CrossRefPubMedPubMedCentral
29.
go back to reference Borrell-Carrió F, Suchman AL, Epstein RM. The biopsychosocial model 25 years later: principles, practice, and scientific inquiry. Ann Fam Med. 2004;2:576.CrossRefPubMedPubMedCentral
Borrell-Carrió F, Suchman AL, Epstein RM. The biopsychosocial model 25 years later: principles, practice, and scientific inquiry. Ann Fam Med. 2004;2:576.CrossRefPubMedPubMedCentral
30.
go back to reference I D, F F-R, S H, Aa L, Jm G, Ms F, et al. ChatGPT is not ready yet for use in providing mental health assessment and interventions. Front Psychiatry [Internet]. 2024;14. Available from: http://pubmed.ncbi.nlm-nih.gov/38239905/. Accessed 23 Jan 2024.
I D, F F-R, S H, Aa L, Jm G, Ms F, et al. ChatGPT is not ready yet for use in providing mental health assessment and interventions. Front Psychiatry [Internet]. 2024;14. Available from: http://pubmed.ncbi.nlm-nih.gov/38239905/. Accessed 23 Jan 2024.
31.
go back to reference Elyoseph Z, Hadar-Shoval D, Asraf K, Lvovsky M. ChatGPT outperforms humans in emotional awareness evaluations. Front Psychol [Internet]. 2023;14. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254409/. Accessed 28 Sept 2023.
Elyoseph Z, Hadar-Shoval D, Asraf K, Lvovsky M. ChatGPT outperforms humans in emotional awareness evaluations. Front Psychol [Internet]. 2023;14. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254409/. Accessed 28 Sept 2023.
32.
go back to reference Bhayana R, Krishna S, Bleakney RR. Performance of ChatGPT on a radiology board-style examination: insights into current strengths and limitations. Radiology. 2023;307:e230582.CrossRefPubMed
Bhayana R, Krishna S, Bleakney RR. Performance of ChatGPT on a radiology board-style examination: insights into current strengths and limitations. Radiology. 2023;307:e230582.CrossRefPubMed
33.
go back to reference Fink MA, Bischoff A, Fink CA, Moll M, Kroschke J, Dulz L, et al. Potential of ChatGPT and GPT-4 for data mining of free-text CT reports on lung cancer. Radiology. 2023;308:e231362.CrossRefPubMed
Fink MA, Bischoff A, Fink CA, Moll M, Kroschke J, Dulz L, et al. Potential of ChatGPT and GPT-4 for data mining of free-text CT reports on lung cancer. Radiology. 2023;308:e231362.CrossRefPubMed
34.
go back to reference Z S, M AW, L N, N N, R S, H F, et al. Evaluation of GPT-4’s chest x-ray impression generation: A reader study on performance and perception. J Med Internet Res [Internet]. 2023;25. Available from: http://pubmed.ncbi.nlm.nih-gov/38133918/. Accessed 23 Jan 2024.
Z S, M AW, L N, N N, R S, H F, et al. Evaluation of GPT-4’s chest x-ray impression generation: A reader study on performance and perception. J Med Internet Res [Internet]. 2023;25. Available from: http://pubmed.ncbi.nlm.nih-gov/38133918/. Accessed 23 Jan 2024.
35.
go back to reference C EM, Z SC, N AT, A KM, S HM, K M. Feasibility and acceptability of ChatGPT generated radiology report summaries for cancer patients. Digit Health [Internet]. 2023;9. Available from: http://pubmed.ncbi.nlm.nih.gov/38130802/. Accessed 23 Jan 2024.
C EM, Z SC, N AT, A KM, S HM, K M. Feasibility and acceptability of ChatGPT generated radiology report summaries for cancer patients. Digit Health [Internet]. 2023;9. Available from: http://pubmed.ncbi.nlm.nih.gov/38130802/. Accessed 23 Jan 2024.
36.
go back to reference Haver HL, Ambinder EB, Bahl M, Oluyemi ET, Jeudy J, Yi PH. Appropriateness of breast cancer prevention and screening recommendations provided by ChatGPT. Radiology. 2023;307:e230424.CrossRefPubMed
Haver HL, Ambinder EB, Bahl M, Oluyemi ET, Jeudy J, Yi PH. Appropriateness of breast cancer prevention and screening recommendations provided by ChatGPT. Radiology. 2023;307:e230424.CrossRefPubMed
37.
go back to reference Martin-Carreras T, Cook TS, Kahn CE Jr. Readability of radiology reports: implications for patient-centered care. Clin Imaging. 2019;54:116–20.CrossRefPubMed
Martin-Carreras T, Cook TS, Kahn CE Jr. Readability of radiology reports: implications for patient-centered care. Clin Imaging. 2019;54:116–20.CrossRefPubMed
38.
go back to reference Lyu Q, Tan J, Zapadka ME, Ponnatapura J, Niu C, Myers KJ, et al. Translating radiology reports into plain language using ChatGPT and GPT-4 with prompt learning: results, limitations, and potential. Vis Comput Ind Biomed Art [Internet]. 2023;6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192466/. Accessed 4 Oct 2023.
Lyu Q, Tan J, Zapadka ME, Ponnatapura J, Niu C, Myers KJ, et al. Translating radiology reports into plain language using ChatGPT and GPT-4 with prompt learning: results, limitations, and potential. Vis Comput Ind Biomed Art [Internet]. 2023;6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192466/. Accessed 4 Oct 2023.
39.
go back to reference New horizons: the potential role of OpenAI’s ChatGPT in clinical radiology. J Am Coll Radiol [Internet]. 2023. Available from: http://www.sciencedirect.com/science/article/pii/S1546144023005367 . Accessed 4 Oct 2023.
New horizons: the potential role of OpenAI’s ChatGPT in clinical radiology. J Am Coll Radiol [Internet]. 2023. Available from: http://www.sciencedirect.com/science/article/pii/S1546144023005367 . Accessed 4 Oct 2023.
40.
go back to reference J K, S B, D J, M A, S AT, T J, et al. ChatGPT makes medicine easy to swallow: an exploratory case study on simplified radiology reports. Eur Radiol [Internet]. 2023. Available from: http://pubmed.ncbi.nlm.nih.gov/37794249/. Accessed 23 Jan 2024.
J K, S B, D J, M A, S AT, T J, et al. ChatGPT makes medicine easy to swallow: an exploratory case study on simplified radiology reports. Eur Radiol [Internet]. 2023. Available from: http://pubmed.ncbi.nlm.nih.gov/37794249/. Accessed 23 Jan 2024.
41.
go back to reference T WCC, N SN, C HY, N HHM, W D, W YTF, et al. Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun Lond Engl [Internet]. 2020;40. Available from: http://pubmed.ncbi.nlm.nih.gov/32301585/. Accessed 10 Oct 2023.
T WCC, N SN, C HY, N HHM, W D, W YTF, et al. Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun Lond Engl [Internet]. 2020;40. Available from: http://pubmed.ncbi.nlm.nih.gov/32301585/. Accessed 10 Oct 2023.
42.
go back to reference O ET, A EB, S O, W MJ, Y PH, M KS. Appropriateness of information provided by ChatGPT regarding breast pathologic diagnoses. AJR Am J Roentgenol [Internet]. 2024. Available from: http://pubmed.ncbi.nlm.nih.gov/38170831/. Accessed 23 Jan 2024.
O ET, A EB, S O, W MJ, Y PH, M KS. Appropriateness of information provided by ChatGPT regarding breast pathologic diagnoses. AJR Am J Roentgenol [Internet]. 2024. Available from: http://pubmed.ncbi.nlm.nih.gov/38170831/. Accessed 23 Jan 2024.
43.
go back to reference Wang AY, Lin S, Tran C, Homer RJ, Wilsdon D, Walsh JC, et al. Assessment of pathology domain-specific knowledge of ChatGPT and comparison to human performance. Arch Pathol Lab Med [Internet]. 2024. Available from: https://doi.org/10.5858/arpa.2023-0296-OA. Accessed 23 Jan 2024.
Wang AY, Lin S, Tran C, Homer RJ, Wilsdon D, Walsh JC, et al. Assessment of pathology domain-specific knowledge of ChatGPT and comparison to human performance. Arch Pathol Lab Med [Internet]. 2024. Available from: https://doi.org/10.5858/arpa.2023-0296-OA. Accessed 23 Jan 2024.
44.
go back to reference Cui C, Shu W, Li P. Fluorescence in situ hybridization: cell-based genetic diagnostic and research applications. Front Cell Dev Biol. 2016;4:207976.CrossRef
Cui C, Shu W, Li P. Fluorescence in situ hybridization: cell-based genetic diagnostic and research applications. Front Cell Dev Biol. 2016;4:207976.CrossRef
45.
go back to reference Ellison G, Zhu G, Moulis A, Dearden S, Speake G, McCormack R. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol. 2013;66:79–89.CrossRefPubMed
Ellison G, Zhu G, Moulis A, Dearden S, Speake G, McCormack R. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol. 2013;66:79–89.CrossRefPubMed
46.
go back to reference Lindeman, Neal I et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. J Thorac Oncol. 2018;13:323–58.
Lindeman, Neal I et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. J Thorac Oncol. 2018;13:323–58.
47.
go back to reference Zhang N-N, Liu Y-T, Ma L, Wang L, Hao X-Z, Yuan Z, et al. The molecular detection and clinical significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK targeted therapy. PLoS ONE. 2014;9:e84501.CrossRefPubMedPubMedCentral
Zhang N-N, Liu Y-T, Ma L, Wang L, Hao X-Z, Yuan Z, et al. The molecular detection and clinical significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK targeted therapy. PLoS ONE. 2014;9:e84501.CrossRefPubMedPubMedCentral
48.
go back to reference S AT, B TM, de M F, F E, G Y, L G, et al. First-Line lorlatinib or crizotinib in advanced ALK-positive lung cancer. N Engl J Med [Internet]. 2020;383. Available from: http://pubmed.ncbi.nlm.nih.gov/33207094/. Accessed 4 Oct 2023.
S AT, B TM, de M F, F E, G Y, L G, et al. First-Line lorlatinib or crizotinib in advanced ALK-positive lung cancer. N Engl J Med [Internet]. 2020;383. Available from: http://pubmed.ncbi.nlm.nih.gov/33207094/. Accessed 4 Oct 2023.
49.
go back to reference Yang, James C-H et al. Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6. Lancet Oncol. 2015;16:830–8.
Yang, James C-H et al. Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6. Lancet Oncol. 2015;16:830–8.
50.
go back to reference Introducing GPTs [Internet]. Available from: https://openai.com/blog/introducing-gpts. Accessed 13 Nov 2023.
Introducing GPTs [Internet]. Available from: https://openai.com/blog/introducing-gpts. Accessed 13 Nov 2023.
51.
go back to reference Airley R. Cancer chemotherapy: basic science to the clinic. John Wiley & Sons; 2009.
Airley R. Cancer chemotherapy: basic science to the clinic. John Wiley & Sons; 2009.
52.
go back to reference Gibson RJ, Keefe DMK. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer. 2006;14:890–900.CrossRefPubMed
Gibson RJ, Keefe DMK. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer. 2006;14:890–900.CrossRefPubMed
53.
go back to reference Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. JNCI J Natl Cancer Inst. 1999;91:1616–34.CrossRefPubMed
Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. JNCI J Natl Cancer Inst. 1999;91:1616–34.CrossRefPubMed
54.
go back to reference Cooper JS, Hanley ME, Hendriksen S, Robins M. Hyperbaric treatment of delayed radiation injury. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470447/. Accessed 4 Oct 2023.
Cooper JS, Hanley ME, Hendriksen S, Robins M. Hyperbaric treatment of delayed radiation injury. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470447/. Accessed 4 Oct 2023.
55.
go back to reference Luqmani YA. Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract. 2008;14:35–48.CrossRef
Luqmani YA. Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract. 2008;14:35–48.CrossRef
56.
go back to reference Moschovi M, Critselis E, Cen O, Adamaki M, Lambrou GI, Chrousos GP, et al. Drugs acting on homeostasis: challenging cancer cell adaptation. Expert Rev Anticancer Ther. 2015;15:1405–17.CrossRefPubMed
Moschovi M, Critselis E, Cen O, Adamaki M, Lambrou GI, Chrousos GP, et al. Drugs acting on homeostasis: challenging cancer cell adaptation. Expert Rev Anticancer Ther. 2015;15:1405–17.CrossRefPubMed
57.
go back to reference Pearse WB, Altman JK, Kircher SM. Perceptions of financial and psychosocial burden among patients with hematologic malignancies treated with novel oral antineoplastic agents. Blood. 2020;136:20.CrossRef
Pearse WB, Altman JK, Kircher SM. Perceptions of financial and psychosocial burden among patients with hematologic malignancies treated with novel oral antineoplastic agents. Blood. 2020;136:20.CrossRef
58.
go back to reference Alizadeh AA, Aranda V, Bardelli A, Blanpain C, Bock C, Borowski C, et al. Toward understanding and exploiting tumor heterogeneity. Nat Med. 2015;21:846–53.CrossRefPubMedPubMedCentral
Alizadeh AA, Aranda V, Bardelli A, Blanpain C, Bock C, Borowski C, et al. Toward understanding and exploiting tumor heterogeneity. Nat Med. 2015;21:846–53.CrossRefPubMedPubMedCentral
59.
go back to reference Marusyk A, Polyak K. Tumor heterogeneity: Causes and consequences. Biochim Biophys Acta BBA - Rev Cancer. 2010;1805:105–17.CrossRef
Marusyk A, Polyak K. Tumor heterogeneity: Causes and consequences. Biochim Biophys Acta BBA - Rev Cancer. 2010;1805:105–17.CrossRef
60.
go back to reference Ferdush J, Begum M, Hossain ST. ChatGPT and clinical decision support: scope, application, and limitations. Ann Biomed Eng. 2024;52(5):1119–24.CrossRefPubMed
Ferdush J, Begum M, Hossain ST. ChatGPT and clinical decision support: scope, application, and limitations. Ann Biomed Eng. 2024;52(5):1119–24.CrossRefPubMed
61.
go back to reference Liao Z, Wang J, Shi Z, Lu L, Tabata H. Revolutionary potential of ChatGPT in constructing intelligent clinical decision support systems. Ann Biomed Eng. 2024;52(2):125–9.CrossRefPubMed
Liao Z, Wang J, Shi Z, Lu L, Tabata H. Revolutionary potential of ChatGPT in constructing intelligent clinical decision support systems. Ann Biomed Eng. 2024;52(2):125–9.CrossRefPubMed
62.
go back to reference Liu S, Wright AP, Patterson BL, Wanderer JP, Turer RW, Nelson SD, et al. Using AI-generated suggestions from ChatGPT to optimize clinical decision support. J Am Med Inform Assoc JAMIA. 2023;30:1237–45.CrossRefPubMed
Liu S, Wright AP, Patterson BL, Wanderer JP, Turer RW, Nelson SD, et al. Using AI-generated suggestions from ChatGPT to optimize clinical decision support. J Am Med Inform Assoc JAMIA. 2023;30:1237–45.CrossRefPubMed
63.
go back to reference Song P, Wu Q, Huang Y. Multidisciplinary team and team oncology medicine research and development in China. Biosci Trends. 2010;4:151–60.PubMed
Song P, Wu Q, Huang Y. Multidisciplinary team and team oncology medicine research and development in China. Biosci Trends. 2010;4:151–60.PubMed
64.
go back to reference Singhi EK, Feldman J, West H (Jack). The multidisciplinary cancer conference. JAMA Oncol. 2023;9:288.CrossRefPubMed
Singhi EK, Feldman J, West H (Jack). The multidisciplinary cancer conference. JAMA Oncol. 2023;9:288.CrossRefPubMed
65.
go back to reference Fleissig A, Jenkins V, Catt S, Fallowfield L. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol. 2006;7:935–43.CrossRefPubMed
Fleissig A, Jenkins V, Catt S, Fallowfield L. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol. 2006;7:935–43.CrossRefPubMed
66.
go back to reference C M, G P, Y IA, B RV, F KM. Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer Amst Neth [Internet]. 2008;60. Available from: http://pubmed.ncbi.nlm.nih/18304687/. Accessed 6 Oct 2023.
C M, G P, Y IA, B RV, F KM. Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer Amst Neth [Internet]. 2008;60. Available from: http://pubmed.ncbi.nlm.nih/18304687/. Accessed 6 Oct 2023.
67.
go back to reference Powell HA, Baldwin DR. Multidisciplinary team management in thoracic oncology: more than just a concept? Eur Respir J. 2014;43:1776–86.CrossRefPubMed
Powell HA, Baldwin DR. Multidisciplinary team management in thoracic oncology: more than just a concept? Eur Respir J. 2014;43:1776–86.CrossRefPubMed
68.
go back to reference C R, C G. The cost of running a multidisciplinary head and neck oncology service--an audit. Rev Laryngol - Otol - Rhinol [Internet]. 2000;121. Available from: http://pubmed.ncbi.nlm.nih.gov/11109879/. Accessed 7 Oct 2023.
C R, C G. The cost of running a multidisciplinary head and neck oncology service--an audit. Rev Laryngol - Otol - Rhinol [Internet]. 2000;121. Available from: http://pubmed.ncbi.nlm.nih.gov/11109879/. Accessed 7 Oct 2023.
69.
go back to reference C SW, C CW, C WJ, W HW, L CS, K T, et al. The now and future of ChatGPT and GPT in psychiatry. Psychiatry Clin Neurosci [Internet]. 2023. Available from: http://pubmed-ncbi.nlm.nih.gov/37612880/. Accessed 7.10.2023.
C SW, C CW, C WJ, W HW, L CS, K T, et al. The now and future of ChatGPT and GPT in psychiatry. Psychiatry Clin Neurosci [Internet]. 2023. Available from: http://pubmed-ncbi.nlm.nih.gov/37612880/. Accessed 7.10.2023.
70.
go back to reference G A, C J, P SL, A SL K, C FA. The exciting potential for ChatGPT in obstetrics and gynecology. Am J Obstet Gynecol [Internet]. 2023;228. Available from: http://pubmed.ncbi.nlm.nih.gov/36924907/. Accessed 7 Oct 2023.
G A, C J, P SL, A SL K, C FA. The exciting potential for ChatGPT in obstetrics and gynecology. Am J Obstet Gynecol [Internet]. 2023;228. Available from: http://pubmed.ncbi.nlm.nih.gov/36924907/. Accessed 7 Oct 2023.
71.
go back to reference K N. Potential applications of ChatGPT in dermatology. J Eur Acad Dermatol Venereol JEADV [Internet]. 2023;37. Available from: http://pubmed.ncbi.nlm.nih.gov/37102458/. Accessed 7 Oct 2023.
K N. Potential applications of ChatGPT in dermatology. J Eur Acad Dermatol Venereol JEADV [Internet]. 2023;37. Available from: http://pubmed.ncbi.nlm.nih.gov/37102458/. Accessed 7 Oct 2023.
72.
go back to reference L J, W C, L S. Utility of ChatGPT in clinical practice. J Med Internet Res [Internet]. 2023;25. Available from: http://pubmed.ncbi.nlm.nih.gov/37379067/. Accessed 7 Oct 2023.
L J, W C, L S. Utility of ChatGPT in clinical practice. J Med Internet Res [Internet]. 2023;25. Available from: http://pubmed.ncbi.nlm.nih.gov/37379067/. Accessed 7 Oct 2023.
73.
go back to reference G AT, O AY, C D. Harnessing generative artificial intelligence to improve efficiency among urologists: welcome ChatGPT. J Urol [Internet]. 2023;209. Available from: http://pubmed.ncbi.nlm.nih.gov/36795957/. Accessed 7 Oct 2023.
G AT, O AY, C D. Harnessing generative artificial intelligence to improve efficiency among urologists: welcome ChatGPT. J Urol [Internet]. 2023;209. Available from: http://pubmed.ncbi.nlm.nih.gov/36795957/. Accessed 7 Oct 2023.
74.
go back to reference F JML, W WB, C LC, R SP, F EK. Beyond chatting: The opportunities and challenges of ChatGPT in medicine and radiology. Diagn Interv Imaging [Internet]. 2023;104. Available from: http://pubmed.ncbi.nlm.nih.gov/36925365/. Accessed 7 Oct 2023.
F JML, W WB, C LC, R SP, F EK. Beyond chatting: The opportunities and challenges of ChatGPT in medicine and radiology. Diagn Interv Imaging [Internet]. 2023;104. Available from: http://pubmed.ncbi.nlm.nih.gov/36925365/. Accessed 7 Oct 2023.
75.
go back to reference S SP, S MJ, P S, N AD, S EH, RK C, et al. Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol Off J Eur Soc Med Oncol [Internet]. 2018;29. Available from: http://pubmed.ncbi.nlm.nih.gov/29324970/. Accessed 7 Oct 2023.
S SP, S MJ, P S, N AD, S EH, RK C, et al. Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol Off J Eur Soc Med Oncol [Internet]. 2018;29. Available from: http://pubmed.ncbi.nlm.nih.gov/29324970/. Accessed 7 Oct 2023.
76.
go back to reference K MS, P HY, K BG, P CK, O IJ, K YC, et al. Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board. Transl Lung Cancer Res [Internet]. 2020;9. Available from: http://pubmed.ncbi.nlm.nih.gov/32676314/.Accessed 7 Oct 2023.
K MS, P HY, K BG, P CK, O IJ, K YC, et al. Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board. Transl Lung Cancer Res [Internet]. 2020;9. Available from: http://pubmed.ncbi.nlm.nih.gov/32676314/.Accessed 7 Oct 2023.
77.
go back to reference Yeo YH, Samaan JS, Ng WH, Ting P-S, Trivedi H, Vipani A, et al. Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma. Clin Mol Hepatol. 2023;29:721–32.CrossRefPubMedPubMedCentral
Yeo YH, Samaan JS, Ng WH, Ting P-S, Trivedi H, Vipani A, et al. Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma. Clin Mol Hepatol. 2023;29:721–32.CrossRefPubMedPubMedCentral
78.
go back to reference M Z, C J, L HA, P TM. Quality of ChatGPT responses to questions related to pancreatic cancer and its surgical care. Ann Surg Oncol [Internet]. 2023;30. Available from: http://pubmed.ncbi.nlm.nih.gov/37349615/. Accessed 7 Oct 2023.
M Z, C J, L HA, P TM. Quality of ChatGPT responses to questions related to pancreatic cancer and its surgical care. Ann Surg Oncol [Internet]. 2023;30. Available from: http://pubmed.ncbi.nlm.nih.gov/37349615/. Accessed 7 Oct 2023.
79.
go back to reference R AA, T N, K GHJ, H C, A F, B A. How AI responds to common lung cancer questions: ChatGPT vs Google Bard. Radiology [Internet]. 2023;307. Available from: http://pubmed.ncbi.nlm.nih.gov/37310252/. Accessed 7 Oct 2023.
R AA, T N, K GHJ, H C, A F, B A. How AI responds to common lung cancer questions: ChatGPT vs Google Bard. Radiology [Internet]. 2023;307. Available from: http://pubmed.ncbi.nlm.nih.gov/37310252/. Accessed 7 Oct 2023.
80.
go back to reference Lukac S, Dayan D, Fink V, Leinert E, Hartkopf A, Veselinovic K, et al. Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases. Arch Gynecol Obstet. 2023;308(6):1831–44.CrossRefPubMedPubMedCentral
Lukac S, Dayan D, Fink V, Leinert E, Hartkopf A, Veselinovic K, et al. Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases. Arch Gynecol Obstet. 2023;308(6):1831–44.CrossRefPubMedPubMedCentral
81.
go back to reference Pressoir M, Desné S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966–71.CrossRefPubMedPubMedCentral
Pressoir M, Desné S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966–71.CrossRefPubMedPubMedCentral
82.
go back to reference Attar A, Malka D, Sabaté JM, Bonnetain F, Lecomte T, Aparicio T, et al. Malnutrition is high and underestimated during chemotherapy in gastrointestinal cancer: an AGEO prospective cross-sectional multicenter study. Nutr Cancer. 2012;64:535–42.CrossRefPubMed
Attar A, Malka D, Sabaté JM, Bonnetain F, Lecomte T, Aparicio T, et al. Malnutrition is high and underestimated during chemotherapy in gastrointestinal cancer: an AGEO prospective cross-sectional multicenter study. Nutr Cancer. 2012;64:535–42.CrossRefPubMed
83.
go back to reference Hébuterne X, Lemarié E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr. 2014;38:196–204.CrossRefPubMed
Hébuterne X, Lemarié E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr. 2014;38:196–204.CrossRefPubMed
84.
go back to reference Bozzetti F, on behalf of the SCRINIO Working Group. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer. 2009;17:279–84.CrossRefPubMed
Bozzetti F, on behalf of the SCRINIO Working Group. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer. 2009;17:279–84.CrossRefPubMed
85.
go back to reference Peltz G. Nutrition support in cancer patients: a brief review and suggestion for standard indications criteria. Nutr J. 2002;1:1.CrossRefPubMedPubMedCentral
Peltz G. Nutrition support in cancer patients: a brief review and suggestion for standard indications criteria. Nutr J. 2002;1:1.CrossRefPubMedPubMedCentral
86.
go back to reference Ravasco P. Nutrition in cancer patients. J Clin Med. 2019;8:1211.CrossRefPubMedPubMedCentral
Ravasco P. Nutrition in cancer patients. J Clin Med. 2019;8:1211.CrossRefPubMedPubMedCentral
87.
go back to reference Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48.CrossRefPubMed
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48.CrossRefPubMed
88.
go back to reference Kaegi-Braun N, Schuetz P, Mueller B, Kutz A. Association of nutritional support with clinical outcomes in malnourished cancer patients: a population-based matched cohort study. Front Nutr [Internet]. 2021;7. Available from: https://www.frontiersin.org/articles/10.3389/fnut.2020.603370. Accessed 19 Nov 2023.
Kaegi-Braun N, Schuetz P, Mueller B, Kutz A. Association of nutritional support with clinical outcomes in malnourished cancer patients: a population-based matched cohort study. Front Nutr [Internet]. 2021;7. Available from: https://www.frontiersin.org/articles/10.3389/fnut.2020.603370. Accessed 19 Nov 2023.
89.
go back to reference Zhang X, Chen X, Yang J, Hu Y, Li K. Effects of nutritional support on the clinical outcomes of well-nourished patients with cancer: a meta-analysis. Eur J Clin Nutr. 2020;74:1389–400.CrossRefPubMed
Zhang X, Chen X, Yang J, Hu Y, Li K. Effects of nutritional support on the clinical outcomes of well-nourished patients with cancer: a meta-analysis. Eur J Clin Nutr. 2020;74:1389–400.CrossRefPubMed
90.
go back to reference K J, R HH, H O, S Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr Edinb Scotl [Internet]. 2003;22. Available from: http://pubmed.ncbi.nlm.nih.gov/12765673/. Accessed 19 Nov 2023.
K J, R HH, H O, S Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr Edinb Scotl [Internet]. 2003;22. Available from: http://pubmed.ncbi.nlm.nih.gov/12765673/. Accessed 19 Nov 2023.
91.
go back to reference B J, C S, F M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr [Internet]. 2002;56. Available from: http://pubmed.ncbi.nlm.nih.gov/12122555/. Accessed 19 Nov 2023.
B J, C S, F M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr [Internet]. 2002;56. Available from: http://pubmed.ncbi.nlm.nih.gov/12122555/. Accessed 19 Nov 2023.
92.
go back to reference Amann J, Blasimme A, Vayena E, Frey D, Madai VI. Explainability for artificial intelligence in healthcare: a multidisciplinary perspective. BMC Med Inform Decis Mak [Internet]. 2020;20. Available from: http://pubmed.ncbi.nlm.nih.gov/33256715/. Accessed 7 Oct 2023.
Amann J, Blasimme A, Vayena E, Frey D, Madai VI. Explainability for artificial intelligence in healthcare: a multidisciplinary perspective. BMC Med Inform Decis Mak [Internet]. 2020;20. Available from: http://pubmed.ncbi.nlm.nih.gov/33256715/. Accessed 7 Oct 2023.
93.
go back to reference Interim Measures for the Management of Generative Artificial Intelligence Services_Office of the Central Cyberspace Affairs Commission [Internet]. Available from: http://www.cac.gov.cn/2023-07/13/c_1690898327029107.htm. Accessed 7 Oct 2023.
Interim Measures for the Management of Generative Artificial Intelligence Services_Office of the Central Cyberspace Affairs Commission [Internet]. Available from: http://www.cac.gov.cn/2023-07/13/c_1690898327029107.htm. Accessed 7 Oct 2023.
94.
go back to reference Masters K. Ethical use of artificial intelligence in health professions education: AMEE Guide No. 158. Med Teach. 2023;45:574–84.CrossRefPubMed
Masters K. Ethical use of artificial intelligence in health professions education: AMEE Guide No. 158. Med Teach. 2023;45:574–84.CrossRefPubMed
95.
go back to reference Azamfirei R, Kudchadkar SR, Fackler J. Large language models and the perils of their hallucinations. Crit Care. 2023;27:120.CrossRefPubMedPubMedCentral
Azamfirei R, Kudchadkar SR, Fackler J. Large language models and the perils of their hallucinations. Crit Care. 2023;27:120.CrossRefPubMedPubMedCentral
96.
go back to reference Su L, Weng L, Li W, Long Y. Applications and challenges of large language models in critical care medicine. Natl Med J China. 2023;103:2361–4.
Su L, Weng L, Li W, Long Y. Applications and challenges of large language models in critical care medicine. Natl Med J China. 2023;103:2361–4.
97.
go back to reference C A, S H. Investigating the impact of user trust on the adoption and use of ChatGPT: survey analysis. J Med Internet Res [Internet]. 2023 [cited 2023 Oct 7];25. Available from: http://pubmed.ncbi.nlm.nih/37314848/. Accessed 7 Oct 2023.
C A, S H. Investigating the impact of user trust on the adoption and use of ChatGPT: survey analysis. J Med Internet Res [Internet]. 2023 [cited 2023 Oct 7];25. Available from: http://pubmed.ncbi.nlm.nih/37314848/. Accessed 7 Oct 2023.
98.
go back to reference G CB, A L, B D, B PF, B N, B AJ, et al. To do no harm - and the most good - with AI in health care. Nat Med [Internet]. 2024;30. Available from: http://pubmed.ncbi.nlm.nih.gov/38388841/. Accessed 26 Mar 2024.
G CB, A L, B D, B PF, B N, B AJ, et al. To do no harm - and the most good - with AI in health care. Nat Med [Internet]. 2024;30. Available from: http://pubmed.ncbi.nlm.nih.gov/38388841/. Accessed 26 Mar 2024.
99.
go back to reference Nacher M, Françoise U, Adenis A. ChatGPT neglects a neglected disease. Lancet Infect Dis. 2024;S1473–3099(23):00750–8.
Nacher M, Françoise U, Adenis A. ChatGPT neglects a neglected disease. Lancet Infect Dis. 2024;S1473–3099(23):00750–8.
100.
go back to reference A R. ChatGPT does not neglect a neglected disease, if appropriately prompted. Lancet Infect Dis [Internet]. 2024. Available from: http://pubmed.ncbi.nlm.nih.gov/38242141/. Accessed 23 Jan 2024.
A R. ChatGPT does not neglect a neglected disease, if appropriately prompted. Lancet Infect Dis [Internet]. 2024. Available from: http://pubmed.ncbi.nlm.nih.gov/38242141/. Accessed 23 Jan 2024.
Metadata
- Title
- ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges
- Authors
-
Zihan Zhou
Peng Qin
Xi Cheng
Maoxuan Shao
Zhaozheng Ren
Yiting Zhao
Qiunuo Li
Lingxiang Liu
- Publication date
- 25-02-2025
- Publisher
- Springer US
- Published in
-
Current Oncology Reports
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269 - DOI
- https://doi.org/10.1007/s11912-025-01649-3
Image Credits
Illustration of communication with chatbot with speech bubbles/© Who is Danny / Stock.adobe.com, Aplastic Anemia/© Springer Healthcare IME, CAR T-cell attacking cancer cells/© Springer Medicine, June 2024, under a creative commons [CCBY] license.